Mai‐Juan Ma

Neutralizing antibody responses to three XBB protein vaccines in older adults

Signal Transduction and Targeted Therapy 2025cited by 5position: lastdoi

Neutralizing antibody durability and SARS-CoV-2 infection in older adults six months after XBB-containing vaccine booster

Signal Transduction and Targeted Therapy 2025cited by 4position: lastdoi

Durability of neutralizing antibody and T-cell responses in COVID-19 patients after infection and booster vaccination

Vaccine X 2025cited by 0position: lastdoi

Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection

Cell Reports 2024cited by 11position: lastdoi

Seroprevalence of SARS-CoV-2 neutralising antibodies and cross-reactivity to JN.1 one year after the BA.5/BF.7 wave in China

The Lancet Regional Health - Western Pacific 2024cited by 7position: lastdoi

Finite immune imprinting on neutralizing antibody responses to Omicron subvariants by repeated vaccinations

International Journal of Infectious Diseases 2024cited by 5position: lastdoi

Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection

Cell Reports 2023cited by 23position: lastdoi

Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection

The Lancet Infectious Diseases 2022cited by 79position: lastdoi

Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection

The Lancet Infectious Diseases 2022cited by 51position: lastdoi

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants

Genome Medicine 2022cited by 22position: lastdoi

Delta Infection After Vaccination Elicits Potent Neutralizing Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron

The Journal of Infectious Diseases 2022cited by 6position: lastdoi

Durability of Neutralization Against Omicron Subvariants after Vaccination and Breakthrough Infection

SSRN Electronic Journal 2022cited by 3position: lastdoi

Delta infection following vaccination elicits potent neutralizing immunity against the SARS-CoV-2 Omicron

Research Square 2022cited by 1position: firstdoi

Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients

Signal Transduction and Targeted Therapy 2021cited by 55position: lastdoi

Serum IP-10 and IL-7 levels are associated with disease severity of coronavirus disease 2019

Cytokine 2021cited by 26position: middledoi

Longitudinal single-cell immune profiling revealed distinct innate immune response in asymptomatic COVID-19 patients

bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 10position: lastdoi

Recent publications